Related Experiment Videos
Cachectin/tumour-necrosis-factor production by cancer patients
Lancet (London, England)
|November 23, 1985
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Primary orbital reconstruction with selective laser melted core patient-specific implants: overview of 100 patients.
The British journal of oral & maxillofacial surgery·2019
Age-specific characteristics of neutrophilic dermatoses and neutrophilic diseases in children.
Journal of the European Academy of Dermatology and Venereology : JEADV·2019
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Pyoderma gangrenosum and Sweet syndrome: the prototypic neutrophilic dermatoses.
The British journal of dermatology·2015
Necroptosis is preceded by nuclear translocation of the signaling proteins that induce it.
Cell death and differentiation·2015
Comparative safety of PICC-ports and chest ports in oncology: A monocentric retrospective cohort study.
The journal of vascular access·2026
Combinatorial effects of curcumin, morin, and phyllanthin in MDA-MB-231 and MCF-7 breast cancer cell lines.
Indian journal of pharmacology·2026
Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Cost-effectiveness analysis of liposomal Irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece.
Expert review of pharmacoeconomics & outcomes research·2026